Figure 3
From: Using description logics to evaluate the consistency of drug-class membership relations in NDF-RT
Defined class Adrenergic Decongestant [EPC]. The appearance of beta2-Adrenergic Agonist [EPC]in Protégé after augmenting it with sufficient conditions.